about
Old and new treatment targets in axial spondyloarthritisHLA-B27 and psoriatic disease: a modern view of an old relationshipEmerging regulators of the inflammatory process in osteoarthritisReview: The interleukin-23/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyondThe intestinal microbiome in spondyloarthritisSolving the puzzle of autoimmunity: critical questionsIdentification of the core regulators of the HLA I-peptide binding processERAP1 reduces accumulation of aberrant and disulfide-linked forms of HLA-B27 on the cell surfaceUpdate on ankylosing spondylitis: current concepts in pathogenesis.Whole Genome Expression Profiling and Signal Pathway Screening of MSCs in Ankylosing Spondylitis.The role of the gut and microbes in the pathogenesis of spondyloarthritis.Juvenile spondyloarthritis.IL-23/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patientsNon-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue.Review: Enthesitis: New Insights Into Pathogenesis, Diagnostic Modalities, and Treatment.Role of HLA-B27 in the pathogenesis of ankylosing spondylitis (Review).Molecular mechanisms for contribution of MHC molecules to autoimmune diseasesThe effects of β-D-mannuronic acid (M2000), as a novel NSAID, on COX1 and COX2 activities and gene expression in ankylosing spondylitis patients and the murine monocyte/macrophage, J774 cell line.The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion.Revisiting MHC genes in spondyloarthritis.Clinical Role of Human Leukocyte Antigen in Health and Disease.Review: animal models as a tool to dissect pivotal pathways driving spondyloarthritis.Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.IL-23/IL-17 axis in spondyloarthritis-bench to bedside.Peptide handling by HLA-B27 subtypes influences their biological behavior, association with ankylosing spondylitis and susceptibility to endoplasmic reticulum aminopeptidase 1 (ERAP1).Causes and consequences of endoplasmic reticulum stress in rheumatic disease.An Update on the Genetic Polymorphism of HLA-B*27 With 213 Alleles Encompassing 160 Subtypes (and Still Counting).Recurrent macrophage activation syndrome since toddler age in an adolescent boy with HLA B27 positive juvenile ankylosing spondylitis.Autologous Graft versus Host Disease: An Emerging Complication in Patients with Multiple MyelomaThe interplay between HLA-B27 and ERAP1/ERAP2 aminopeptidases: from anti-viral protection to spondyloarthritis.Bone Wasn't Built in a Day: Destruction and Formation of Bone in the Rheumatic Diseases.Soluble Flt-1 improves the repair of ankle joint injury in rats.The Protective Effect of Chrysanthemum indicum Extract against Ankylosing Spondylitis in Mouse Models.Discovery of T Cell Receptor β Motifs Specific to HLA-B27-Positive Ankylosing Spondylitis by Deep Repertoire Sequence Analysis.Differentially expressed mRNAs, lncRNAs, and miRNAs with associated co-expression and ceRNA networks in ankylosing spondylitis.Whole-genome single nucleotide polymorphism-based linkage analysis in spondyloarthritis multiplex families reveals a new susceptibility locus in 13q13.Tenascin-C, a biomarker of disease activity in early ankylosing spondylitis.Regulation of Cytokine Production by the Unfolded Protein Response; Implications for Infection and Autoimmunity.Role of Interleukin- (IL-) 17 in the Pathogenesis and Targeted Therapies in Spondyloarthropathies.IRE1α Implications in Endoplasmic Reticulum Stress-Mediated Development and Pathogenesis of Autoimmune Diseases.
P2860
Q26777906-DF3A91D5-CE54-46DE-8701-9CD6F9366B58Q26796433-631F8AD1-23FD-4BCA-99FF-02EFB34A63EFQ26829840-7EDEE236-51E8-4CB2-B324-F799F2279C42Q26991709-B7E16557-694D-41F4-87A9-CF5FE441B6A2Q28080969-7501A047-3851-460A-B678-B602C9DBCA48Q28084677-9774C1BE-44E2-4F0F-9B90-517A4227626DQ29048598-B42E6507-ED43-4486-B7A6-2587D309095EQ33660017-D7724656-995B-43E1-8A00-5CD9E25683F4Q34450732-9B63D81C-FF9F-4700-B4C6-9FA36B0CB463Q34721995-865AE108-0603-4568-BA28-EFF7D2C5BB50Q34942393-2CA6B98E-92B6-424E-B4EE-EA6BEDAB4E22Q35800954-30E43865-324B-4870-8ACC-4E01A97EDFF2Q36611562-9B1E5EC6-B8DD-446E-9146-EB09EC000778Q36913820-6F622E52-3AF6-4E34-9351-4830E3C3B5AEQ37541327-4BD53CE7-937F-4D37-B593-161D211D97CFQ37720215-9A12D109-B25D-45D6-A272-0C346E196A65Q38248679-05BC4674-BD08-4928-8A55-3E9E78D3C5CDQ38371958-0D265BA7-27CB-47C7-A5C2-25222B1A9E62Q38380973-1DF9D42A-50F9-4D94-9A92-FF4878E8E90FQ38436508-4874E99D-708A-481E-9AFB-A868D6664E32Q38534421-7CD2F1F4-1AA3-4640-B718-79C077DFB7A8Q38555291-9FFA80A3-E37B-4189-8198-E77823EE81D8Q38593977-E355A261-BB22-406C-97E8-679D30DAD3ADQ38807623-43F24AC0-8809-4597-A49F-4CD70C7DAC7FQ38959953-E137D055-26FA-4AAB-BAAB-147F205F2C7BQ39025066-733CAFF5-A470-46E9-ADC5-E898F2EE425EQ39155771-D3914C01-50ED-4CF0-8C80-48F9ADB9D7CBQ39203211-7B11B588-7074-49A7-AA11-DA019B449ACEQ39698910-1B9B77D8-9F6A-422D-B57F-EBBE158BC244Q40101435-406B68EE-7A17-4890-8A81-81995B2AE0FAQ41112237-2EE0BADD-5FEC-48CC-BB06-62E0241401DAQ41894551-046C9354-20D4-4A30-B524-4DFC0CB165C7Q42045975-50DDB385-6BD6-49E9-A238-2E9F1908DC62Q45281583-EAC770E7-6270-4372-A01E-7F31AA5CBD31Q47710960-FCEC9694-F49A-4F9A-B1E9-5D4062D14158Q48146310-F05B08EB-B451-4340-8808-617451FC5275Q50127590-207611CF-DF2D-4A7A-9930-6C6205866895Q55260956-6ABBEE77-E695-4CD4-8E42-E5675CE6E8DEQ55265241-14DEEBB2-8462-4F73-9714-57554365C52FQ55283549-8CF89C1A-6938-4557-A4C8-7FDF73EFEE09
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
HLA-B27 misfolding and ankylosing spondylitis
@ast
HLA-B27 misfolding and ankylosing spondylitis
@en
HLA-B27 misfolding and ankylosing spondylitis
@nl
type
label
HLA-B27 misfolding and ankylosing spondylitis
@ast
HLA-B27 misfolding and ankylosing spondylitis
@en
HLA-B27 misfolding and ankylosing spondylitis
@nl
prefLabel
HLA-B27 misfolding and ankylosing spondylitis
@ast
HLA-B27 misfolding and ankylosing spondylitis
@en
HLA-B27 misfolding and ankylosing spondylitis
@nl
P2093
P2860
P3181
P1433
P1476
HLA-B27 misfolding and ankylosing spondylitis
@en
P2093
Gerlinde Layh-Schmitt
Robert A. Colbert
Tri M. Tran
P2860
P3181
P356
10.1016/J.MOLIMM.2013.07.013
P407
P577
2014-01-01T00:00:00Z